<?xml version='1.0' encoding='utf-8'?>
<document id="27046219"><sentence text="Delirium associated with concomitant use of duloxetine and bupropion in an elderly patient."><entity charOffset="44-54" id="DDI-PubMed.27046219.s1.e0" text="duloxetine" /><entity charOffset="59-68" id="DDI-PubMed.27046219.s1.e1" text="bupropion" /><pair ddi="false" e1="DDI-PubMed.27046219.s1.e0" e2="DDI-PubMed.27046219.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27046219.s1.e0" e2="DDI-PubMed.27046219.s1.e1" /></sentence><sentence text="Delirium is common in daily practice" /><sentence text=" Drug-induced delirium constitutes approximately one-third of all cases of delirium" /><sentence text=" In cases characterized by the limited efficacy of a single antidepressant, a combination of two antidepressants is required, which may induce a complex drug-drug interaction" /><sentence text=" We reviewed a case of duloxetine- and bupropion-related delirium in an elderly male patient in our clinical practice"><entity charOffset="23-34" id="DDI-PubMed.27046219.s5.e0" text="duloxetine-" /><entity charOffset="39-48" id="DDI-PubMed.27046219.s5.e1" text="bupropion" /><pair ddi="false" e1="DDI-PubMed.27046219.s5.e0" e2="DDI-PubMed.27046219.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27046219.s5.e0" e2="DDI-PubMed.27046219.s5.e1" /></sentence><sentence text=" The patient was diagnosed with major depressive disorder and was treated with duloxetine"><entity charOffset="79-89" id="DDI-PubMed.27046219.s6.e0" text="duloxetine" /></sentence><sentence text=" However, he developed delirium 10 days after bupropion was added to his treatment regimen"><entity charOffset="46-55" id="DDI-PubMed.27046219.s7.e0" text="bupropion" /></sentence><sentence text=" Three days after the cessation of bupropion, his delirious condition gradually improved"><entity charOffset="35-44" id="DDI-PubMed.27046219.s8.e0" text="bupropion" /></sentence><sentence text=" Duloxetine and bupropion are both cytochrome P450 2D6 inhibitors that may result in a higher level of hydroxybupropion"><entity charOffset="1-11" id="DDI-PubMed.27046219.s9.e0" text="Duloxetine" /><entity charOffset="16-25" id="DDI-PubMed.27046219.s9.e1" text="bupropion" /><entity charOffset="103-119" id="DDI-PubMed.27046219.s9.e2" text="hydroxybupropion" /><pair ddi="false" e1="DDI-PubMed.27046219.s9.e0" e2="DDI-PubMed.27046219.s9.e0" /><pair ddi="false" e1="DDI-PubMed.27046219.s9.e0" e2="DDI-PubMed.27046219.s9.e1" /><pair ddi="false" e1="DDI-PubMed.27046219.s9.e0" e2="DDI-PubMed.27046219.s9.e2" /><pair ddi="false" e1="DDI-PubMed.27046219.s9.e1" e2="DDI-PubMed.27046219.s9.e1" /><pair ddi="false" e1="DDI-PubMed.27046219.s9.e1" e2="DDI-PubMed.27046219.s9.e2" /></sentence><sentence text=" An increased level of hydroxybupropion may cause the elevation of dopamine and a risk of subsequent delirium"><entity charOffset="23-39" id="DDI-PubMed.27046219.s10.e0" text="hydroxybupropion" /><entity charOffset="67-75" id="DDI-PubMed.27046219.s10.e1" text="dopamine" /><pair ddi="false" e1="DDI-PubMed.27046219.s10.e0" e2="DDI-PubMed.27046219.s10.e0" /><pair ddi="false" e1="DDI-PubMed.27046219.s10.e0" e2="DDI-PubMed.27046219.s10.e1" /></sentence><sentence text=" We should be aware of the risk of delirium induced by drug-drug interactions" /><sentence text="" /></document>